Frontlight ResearchEarly access
Trial site
Moscow
- 5running trials
- 9closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis3 trials
- Atopic dermatitis (eczema)2 trials
- COPD2 trials
- Multiple myeloma2 trials
- Asthma1 trial
- Gaucher disease1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 36 trials
- Phase 25 trials
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting4 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Sanofi13 trials
- Genzyme, a Sanofi Company1 trial
Running trials
Enrolling by invitation
Active, not recruiting
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
Active, not recruiting
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
Active, not recruiting
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma1 recruiting
Closed trials
Terminated
Completed
Completed
Completed
Completed
Recruiting
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026